Research also reported that polygenetic risk scores combining PNPLA3, GCKR, and TM6SF2 were significantly associated with an increased risk of NAFLD in obese patients [78]. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.